Formula: | C21H27N3O3 |
Molecular Weight: | 369.46 |
Rotatable Bond Donors: | 7 |
clogP: | 2.67 |
Topological Polar Surface Area: | 93.45 |
Lipinski's RO5: | MW: 369.46 HBA: 6 HBD: 4 RB: 7 LogP: 2.67 |
Rule of Three: | MW: 369.46 HBA: 6 HBD: 4 RB: 7 LogP: 2.67 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC390832666 | 1.0 | ZINC390832666 RDKit 3D 27 28 0 0 0 0 0 0 0 0999 V2000 0.6222 1.5941 -2.7541 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9490 1.8844 -2.0914 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7337 2.6441 -0.8010 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7635 2.7494 -3.0250 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6936 0.6906 -1.8769 O 0 0 0 0 0 0 0 0 0 0 0 0 2.0962 -0.1540 -0.9078 C 0 0 1 0 0 0 0 0 0 0 0 0 1.1987 -1.2800 -1.4370 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1303 -1.6356 -2.6124 O 0 0 0 0 0 0 0 0 0 0 0 0 0.4247 -1.8381 -0.4358 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.6249 -2.7681 -0.7614 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6970 -2.1386 -1.6352 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6946 -1.4445 -0.8557 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.4750 -0.1616 -0.3936 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4429 0.4631 -0.6082 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.5996 0.4144 0.3954 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7617 -0.3530 0.5458 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.8505 0.1258 1.2685 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7889 1.3844 1.8520 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6384 2.1554 1.7096 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5355 1.6857 0.9853 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4092 2.5258 0.8932 N 0 0 0 0 0 0 0 0 0 0 0 0 3.1656 -0.6481 0.0221 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1482 -0.2331 1.3545 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1288 -0.6746 2.2394 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1319 -1.5323 1.7953 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1560 -1.9486 0.4668 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1756 -1.5072 -0.4183 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 2 4 1 0 2 5 1 0 6 5 1 6 6 7 1 0 7 8 2 0 7 9 1 0 9 10 1 0 10 11 1 0 11 12 1 0 12 13 1 0 13 14 2 0 13 15 1 0 15 16 2 0 16 17 1 0 17 18 2 0 18 19 1 0 19 20 2 0 20 21 1 0 6 22 1 0 22 23 2 0 23 24 1 0 24 25 2 0 25 26 1 0 26 27 2 0 20 15 1 0 27 22 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |